Menu
No results found.
Weekly Share Price & Valuation Overview
Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- HKD 68.93B
- Enterprise Value Operating value: market cap + total debt − cash.
- HKD 73.88B
- Total Revenue (TTM) Estimated Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- HKD 68.31B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- HKD 29.64B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- HKD 10.12B
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- HKD 74.32
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 1.28
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 6.64%
- Shares Outstanding
- 919.07M
- Float Shares
- 1.58B
- Implied Shares Outstanding
- 5.42B
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
3.22%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
14.82%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
43.40%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
1.57%
- ROA Return on assets: net income ÷ total assets.
-
2.42%
- ROE Return on equity: net income ÷ shareholder equity.
-
6.74%
- Revenue Growth Year-over-year revenue growth.
-
0.90%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-14.30%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-13.60%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.04
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.70
- Total Cash Cash and equivalents.
- HKD 45.03B
- Total Debt Short + long-term interest-bearing debt.
- HKD 59.45B
- Net Debt Total debt − cash (negative = net cash).
- HKD 14.42B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 5.87
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- HKD 9.10B
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- HKD 3.87B
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
13.32%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
5.66%
- Cash Conversion (OpCF/EBITDA)
- 0.90
- Total Revenue (TTM) estimated from Revenue per Share × Shares due to feed inconsistency.
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.